Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Liabilities and Shareholders Equity (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Liabilities and Shareholders Equity readings, the most recent being $40.4 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 31.68% to $40.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $165.1 million, a 38.2% increase, with the full-year FY2025 number at $40.4 million, up 31.68% from a year prior.
  • Liabilities and Shareholders Equity hit $40.4 million in Q4 2025 for Lucid Diagnostics, down from $53.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $62.1 million in Q1 2022 to a low of $3.3 million in Q3 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $36.2 million (2022), compared with a mean of $37.6 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 2587.88% in 2021 and later tumbled 44.9% in 2022.
  • Lucid Diagnostics' Liabilities and Shareholders Equity stood at $59.0 million in 2021, then plummeted by 44.9% to $32.5 million in 2022, then dropped by 16.12% to $27.3 million in 2023, then grew by 12.63% to $30.7 million in 2024, then skyrocketed by 31.68% to $40.4 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $40.4 million (Q4 2025), $53.2 million (Q3 2025), and $38.7 million (Q2 2025) per Business Quant data.